Ascend Laboratories, LLC recalls Dabigatran Etexilate Capsules
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
- Products
-
- Dabigatran Etexilate Capsules
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
USA Nationwide
Nationwide
- Units affected
- 3,600 cartons x 6 x 10 (in blister pack)
- About this recall
- Dabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, INDIA, Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268, NDC 0904-7255-68.